Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey
Description
The Covid-19 pandemic required many clinical trials to adopt a decentralized framework to continue research activities during lock down restrictions. The STOPCoV study was designed to assess the safety and efficacy of Covid-19 vaccines in those aged
